Zosano Pharma (ZSAN) Reports Q4 Loss of $0.34; CEO Resigns

Zosano Pharma (NASDAQ: ZSAN) reported Q4 EPS of ($0.34), versus ($0.68) reported last year.

In addition, John P. Walker, Chairman of the company’s Board of Directors, has been named Interim Chief Executive Officer to replace Konstantinos Alataris who has resigned as CEO and director of the company. Georgia Erbez, our Chief Business Officer and Interim Chief Financial Officer, has assumed full responsibility for both functions.

For earnings history and earnings-related data on Zosano Pharma (ZSAN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c